VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2022 | Gastric cancer updates at ESMO 2022

Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, provides an overview of the latest news in gastric cancers from the European Society for Medical Oncology (ESMO) 2022 Congress, including updates on the use of trastuzumab deruxtecan, as well as the role of upfront chemotherapy. Dr Kohei anticipates results from Claudin 18.2 targeting therapies, as well as FGFR-targeting approaches. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter